Seltorexant not checked

Janssen Research & Development, LLC · JNJ-42847922 · MIN-202

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
26 in total · 1 in the EU

What this is

How it works
How it works isn't classified yet
Tested for
Depressive Disorder, Major (2 trials)
Main trialPhase 3
“The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with placebo as an adjunctive therapy to an antidepressant in improving depressive symptoms in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).”In the company’s words, NCT06559306 on ClinicalTrials.gov
Other names
JNJ-42847922 · MIN-202 · JNJ-42827922

Other drugs for Depressive Disorder, Major

All 36 drugs for Depressive Disorder, Major

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials26

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Dec 2026 Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Phase 3Recruiting 24 Aug 2028 A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Phase 3Terminated 24 May 2022 A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
Phase 3Completed 25 Apr 2023 A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
Phase 3Completed 3 Oct 2023 A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
Phase 2Completed 2 Dec 2015 Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity
Phase 2Completed 12 Jan 2019 A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Phase 2Completed 3 Apr 2019 A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
Phase 2Completed 13 Jun 2019 A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Phase 2Completed 10 Nov 2023 A Study of Seltorexant in Participants With Probable Alzheimer's Disease
Phase 1Completed Jul 2015 A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants
Phase 1Completed 4 Jan 2016 A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder
Phase 1Completed Feb 2016 A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922
Phase 1Completed 24 Nov 2017 A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants
Phase 1Completed 30 May 2018 A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted Conditions
Phase 1Completed 13 Aug 2018 A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants
Phase 1Completed 29 Apr 2019 A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder
Phase 1Completed 7 Jun 2019 A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea
Phase 1Completed 23 Aug 2019 A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants
Phase 1Completed 20 Dec 2020 A Study of Seltorexant in Healthy Participants
Phase 1Completed 19 Nov 2021 A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants
Phase 1Completed 1 Mar 2022 A Study of JNJ-42847922 (Seltorexant) in Healthy Participants
Phase 1Completed 18 Oct 2022 A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants
Phase 1Completed 16 Mar 2023 A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder
Phase 1Completed 12 May 2023 A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem
Phase 1Terminated 8 Apr 2024 A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Seltorexant

Following is part of Solo: you see every change to Seltorexant the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in